Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
Neurocrine's VMAT-2 Enters Phase IIbJason Napodano • Tue, Oct 2, 2012
-
-
-
Neurocrine Could Be A Major Biotech Comeback StoryStephen Simpson • Mon, Mar 19, 2012
-
-
-
-
-
-
-
-
Neurocrine Biosciences: Lessons From Its Collapse (NBIX)Roger Nusbaum • Wed, May 17, 2006
-
-
-
-
-
-
-
-
3 Small Cap Stocks With Growth On The Horizon That Are Churning Out ProfitsZetaKap • Tue, Aug 21, 2012
-
-
-
-
-
-
-
Tuesday Options RecapFrederic Ruffy • Tue, Mar 27, 2012 -
-
-
-
Insiders Love These 18 High Growth StocksKapitall • Wed, Jan 18, 2012
-
-
at MarketWatch.com (Jun 4, 2013)
-
at CNBC.com (May 29, 2013)
-
PR Newswire (May 29, 2013)
-
PR Newswire (May 23, 2013)
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (Apr 26, 2013)
-
PR Newswire (Apr 24, 2013)
-
at CNBC.com (Apr 11, 2013)
-
PR Newswire (Mar 27, 2013)
-
PR Newswire (Mar 11, 2013)
-
PR Newswire (Feb 27, 2013)
-
PR Newswire (Feb 8, 2013)
-
PR Newswire (Feb 6, 2013)
-
PR Newswire (Nov 27, 2012)
-
PR Newswire (Nov 20, 2012)
-
PR Newswire (Nov 6, 2012)
NBIX vs. ETF Alternatives
Company Description
Currently, there's no company description for NBIX.
